Basic information
Biomarker: Intratumoral CD8+ T lymphocytes
Full name: Intratumoral CD8+ T lymphocytes
Clinical application: prognosis
Histology type: endometrial carcinoma
Cohort characteristics
Country: Israel
Region: Haifa
Followed up time : 60 months (range, 1-106 months)
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 180 | EC | 90 | EEC | 75 | papillary serous carcinomas | 15 |
Sample information
Sample type : tissue
Clinical method: immunohistochemistry
Expression pattern : upregulated
Biomarker characteristic: Increased number
